Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 20

1.

Previous Surgery and Hypoglossal Nerve Stimulation for Obstructive Sleep Apnea.

Kezirian EJ, Heiser C, Steffen A, Boon M, Hofauer B, Doghramji K, Maurer JT, Sommer JU, Soose RJ, Schwab R, Thaler E, Withrow K, Kominsky A, Larsen CG, Hsia J, Mehra R, Waters T, Strohl K.

Otolaryngol Head Neck Surg. 2019 Jun 25:194599819856339. doi: 10.1177/0194599819856339. [Epub ahead of print]

PMID:
31234734
2.

Upper Airway Stimulation Response in Older Adults with Moderate to Severe Obstructive Sleep Apnea.

Withrow K, Evans S, Harwick J, Kezirian E, Strollo P.

Otolaryngol Head Neck Surg. 2019 May 14:194599819848709. doi: 10.1177/0194599819848709. [Epub ahead of print]

PMID:
31084350
3.

Increasing preoperative apnea severity improves upper airway stimulation response in OSA treatment.

Evans SS, Richman J, Cho DY, Withrow K.

Laryngoscope. 2019 Apr 30. doi: 10.1002/lary.28009. [Epub ahead of print]

PMID:
31038747
4.

Post-approval upper airway stimulation predictors of treatment effectiveness in the ADHERE registry.

Heiser C, Steffen A, Boon M, Hofauer B, Doghramji K, Maurer JT, Sommer JU, Soose R, Strollo PJ Jr, Schwab R, Thaler E, Withrow K, Kominsky A, Larsen C, Kezirian EJ, Hsia J, Chia S, Harwick J, Strohl K, Mehra R; ADHERE registry investigators.

Eur Respir J. 2019 Jan 3;53(1). pii: 1801405. doi: 10.1183/13993003.01405-2018. Print 2019 Jan.

5.

Early feasibility of hypoglossal nerve upper airway stimulator in patients with cardiac implantable electronic devices and continuous positive airway pressure-intolerant severe obstructive sleep apnea.

Parikh V, Thaler E, Kato M, Gillespie MB, Nguyen S, Withrow K, Calhoun D, Soose R, Stevens D, Stevens S, Larsen C, Reddy M, Lakkireddy D.

Heart Rhythm. 2018 Aug;15(8):1165-1170. doi: 10.1016/j.hrthm.2018.04.016. Epub 2018 Apr 18.

PMID:
29678782
6.

Upper Airway Stimulation for Obstructive Sleep Apnea: Results from the ADHERE Registry.

Boon M, Huntley C, Steffen A, Maurer JT, Sommer JU, Schwab R, Thaler E, Soose R, Chou C, Strollo P, Kezirian EJ, Chia S, Withrow K, Weidenbecher M, Strohl K, Doghramji K, Hofauer B, Heiser C; ADHERE Registry Investigators.

Otolaryngol Head Neck Surg. 2018 Aug;159(2):379-385. doi: 10.1177/0194599818764896. Epub 2018 Mar 20.

PMID:
29557280
7.

Characterizing the Utility and Limitations of Repurposing an Open-Field Optical Imaging Device for Fluorescence-Guided Surgery in Head and Neck Cancer Patients.

Moore LS, Rosenthal EL, Chung TK, de Boer E, Patel N, Prince AC, Korb ML, Walsh EM, Young ES, Stevens TM, Withrow KP, Morlandt AB, Richman JS, Carroll WR, Zinn KR, Warram JM.

J Nucl Med. 2017 Feb;58(2):246-251. doi: 10.2967/jnumed.115.171413. Epub 2016 Sep 1.

8.

A ratiometric threshold for determining presence of cancer during fluorescence-guided surgery.

Warram JM, de Boer E, Moore LS, Schmalbach CE, Withrow KP, Carroll WR, Richman JS, Morlandt AB, Brandwein-Gensler M, Rosenthal EL.

J Surg Oncol. 2015 Jul;112(1):2-8. doi: 10.1002/jso.23946. Epub 2015 Jun 12.

9.

Outcomes of Holmium Laser-Assisted Lithotripsy with Sialendoscopy in Treatment of Sialolithiasis.

Phillips J, Withrow K.

Otolaryngol Head Neck Surg. 2014 Jun;150(6):962-7. doi: 10.1177/0194599814524716. Epub 2014 Mar 5.

PMID:
24598407
10.

Provision of genetic services for hearing loss: results from a national survey and comparison to insights obtained from previous focus group discussions.

Withrow KA, Tracy KA, Burton SK, Norris VW, Maes HH, Arnos KS, Pandya A.

J Genet Couns. 2009 Dec;18(6):618-21. doi: 10.1007/s10897-009-9246-8. Epub 2009 Oct 2.

PMID:
19798556
11.

Impact of genetic advances and testing for hearing loss: results from a national consumer survey.

Withrow KA, Tracy KA, Burton SK, Norris VW, Maes HH, Arnos KS, Pandya A.

Am J Med Genet A. 2009 Jun;149A(6):1159-68. doi: 10.1002/ajmg.a.32800.

PMID:
19449400
12.

Consumer motivations for pursuing genetic testing and their preferences for the provision of genetic services for hearing loss.

Withrow KA, Burton S, Arnos KS, Kalfoglou A, Pandya A.

J Genet Couns. 2008 Jun;17(3):252-60. doi: 10.1007/s10897-007-9143-y. Epub 2008 Feb 5.

PMID:
18247107
13.

Assessment of bevacizumab conjugated to Cy5.5 for detection of head and neck cancer xenografts.

Withrow KP, Newman JR, Skipper JB, Gleysteen JP, Magnuson JS, Zinn K, Rosenthal EL.

Technol Cancer Res Treat. 2008 Feb;7(1):61-6.

PMID:
18198926
14.

Assessment of indocyanine green-labeled cetuximab to detect xenografted head and neck cancer cell lines.

Withrow KP, Gleysteen JP, Safavy A, Skipper J, Desmond RA, Zinn K, Rosenthal EL.

Otolaryngol Head Neck Surg. 2007 Nov;137(5):729-34.

PMID:
17967636
15.

Free tissue transfer to manage salvage laryngectomy defects after organ preservation failure.

Withrow KP, Rosenthal EL, Gourin CG, Peters GE, Magnuson JS, Terris DJ, Carroll WW.

Laryngoscope. 2007 May;117(5):781-4.

PMID:
17473668
16.

A focus group study of consumer attitudes toward genetic testing and newborn screening for deafness.

Burton SK, Withrow K, Arnos KS, Kalfoglou AL, Pandya A.

Genet Med. 2006 Dec;8(12):779-83.

PMID:
17172941
17.

Transition: the birth of a new practice.

Withrow KK.

AWHONN Lifelines. 2006 Oct-Nov;10(5):440, 439. No abstract available.

PMID:
17069578
18.

Parathyromatosis and recurrent hyperparathyroidism.

Lentsch EJ, Withrow KP, Ackermann D, Bumpous JM.

Arch Otolaryngol Head Neck Surg. 2003 Aug;129(8):894-6.

PMID:
12925351
19.

QTc prolongation and high-dose olanzapine.

Dineen S, Withrow K, Voronovitch L, Munshi F, Nawbary MW, Lippmann S.

Psychosomatics. 2003 Mar-Apr;44(2):174-5. No abstract available.

PMID:
12618539
20.

SITA standard in optic neuropathies and hemianopias: a comparison with full threshold testing.

Wall M, Punke SG, Stickney TL, Brito CF, Withrow KR, Kardon RH.

Invest Ophthalmol Vis Sci. 2001 Feb;42(2):528-37.

PMID:
11157893

Supplemental Content

Loading ...
Support Center